<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS199174</article-id><article-id pub-id-type="doi">10.1101/2024.09.30.615797</article-id><article-id pub-id-type="archive">PPR918316</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Acid excretion is impaired in calcium oxalate stone formers</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Silva</surname><given-names>Pedro H Imenez</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Dhayat</surname><given-names>Nasser A.</given-names></name><xref ref-type="aff" rid="A4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fuster</surname><given-names>Daniel G.</given-names></name><xref ref-type="aff" rid="A5">5</xref></contrib><contrib contrib-type="author"><name><surname>Seeger</surname><given-names>Harald</given-names></name><xref ref-type="aff" rid="A6">6</xref><xref ref-type="aff" rid="A7">7</xref></contrib><contrib contrib-type="author"><name><surname>Ritter</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="A8">8</xref></contrib><contrib contrib-type="author"><name><surname>Ernandez</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Buchkremer</surname><given-names>Florian</given-names></name><xref ref-type="aff" rid="A9">9</xref></contrib><contrib contrib-type="author"><name><surname>Roth</surname><given-names>Beat</given-names></name><xref ref-type="aff" rid="A10">10</xref></contrib><contrib contrib-type="author"><name><surname>Bonny</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="A11">11</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A12">12</xref></contrib><contrib contrib-type="author"><name><surname>Rubio-Aliaga</surname><given-names>Isabel</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wagner</surname><given-names>Carsten A.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Institute of Physiology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>University of Zurich</institution></institution-wrap>, <city>Zurich</city>, <country country="CH">Switzerland</country></aff><aff id="A2"><label>2</label>National Center of Competence of Research NCCR Kidney.CH</aff><aff id="A3"><label>3</label>Department of Internal Medicine, Division of Nephrology and Transplantation, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/018906e22</institution-id><institution>Erasmus Medical Center</institution></institution-wrap>, University Medical Center, <city>Rotterdam</city>, <country country="NL">The Netherlands</country></aff><aff id="A4"><label>4</label>Nephrology &amp; Dialysis Care Center, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/0552cbh05</institution-id><institution>B. Braun Medical Care AG</institution></institution-wrap>, <city>Hochfelden, Zurich</city>, <country country="CH">Switzerland</country></aff><aff id="A5"><label>5</label>Department of Nephrology and Hypertension, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q9sj412</institution-id><institution>Inselspital, Bern University Hospital</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02k7v4d05</institution-id><institution>University of Bern</institution></institution-wrap>, <country country="CH">Switzerland</country></aff><aff id="A6"><label>6</label>Division of Nephrology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01462r250</institution-id><institution>University Hospital Zurich</institution></institution-wrap>, <city>Zurich</city>, <country country="CH">Switzerland</country></aff><aff id="A7"><label>7</label>Institute for Nephrology and Dialysis, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/034e48p94</institution-id><institution>Cantonal Hospital Baden</institution></institution-wrap>, <city>Baden</city>, <country country="CH">Switzerland</country></aff><aff id="A8"><label>8</label>Clinic for Nephrology and Transplantation Medicine, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/00gpmb873</institution-id><institution>Cantonal Hospital St.Gallen</institution></institution-wrap>, <city>St.Gallen</city>, <country country="CH">Switzerland</country></aff><aff id="A9"><label>9</label>Division of Nephrology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/056tb3809</institution-id><institution>Kantonsspital Aarau</institution></institution-wrap>, <city>Aarau</city>, <country country="CH">Switzerland</country></aff><aff id="A10"><label>10</label>Department of Urology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q9sj412</institution-id><institution>Inselspital, Bern University Hospital</institution></institution-wrap>, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/02k7v4d05</institution-id><institution>University of Bern</institution></institution-wrap>, <country country="CH">Switzerland</country></aff><aff id="A11"><label>11</label>Service of Nephrology, Fribourg State Hospital and <institution-wrap><institution-id institution-id-type="ror">https://ror.org/022fs9h90</institution-id><institution>University of Fribourg</institution></institution-wrap>, <city>Fribourg</city>, <country country="CH">Switzerland</country></aff><aff id="A12"><label>12</label>Service of Nephrology, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/019whta54</institution-id><institution>Lausanne University Hospital</institution></institution-wrap>, <city>Lausanne</city>, <country country="CH">Switzerland</country></aff><author-notes><corresp id="CR1">
<label>*</label><bold>Corresponding authors</bold> Pedro H Imenez Silva, <email>p.imenezsilva@erasmusmc.nl</email> Carsten A Wagner, <email>wagnerca@access.uzh.ch</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>04</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>01</day><month>10</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><sec id="S1"><title>Background</title><p id="P1">Urine pH is a key factor in kidney stone formation. We aimed to identify whether acid excretion capacity is disturbed in calcium oxalate (CaOx) or calcium phosphate (CaP) stone formers.</p></sec><sec id="S2"><title>Method</title><p id="P2">Urinary, serum, clinical, and anthropomorphic baseline data were obtained from the Swiss Kidney Stone Cohort, a prospective, longitudinal, and multi-centric observational study. We included in this study 193 non-stone formers (NSF, confirmed by negative CT scan), and 309 CaOx and 28 CaP stone formers. Titratable acids, net acid excretion (NAE), NAE capacity (NAEC) and acid-base (AB) score were calculated. Logistic regression analyses were used to estimate the potential associations of various acid-base variables with the occurrence of CaOx kidney stones.</p></sec><sec id="S3"><title>Results</title><p id="P3">CaOx stone formers showed a disturbed capacity to excrete acids in comparison to NSF (NAEC NSF = 3.49±12.6 mmol/24h; CaOx = -1.06±13.10; CaP = 0.97±14.70 and AB score NSF = 20.5±6.36 mmol/24h; CaOx = 17.9± 6.53; CaP = 18.8±6.10). The correlation between urine calcium and urine pH was altered in CaOx stone formers and between urine calcium and NAE was stronger in CaP stone formers. Logistic models showed that urinary ammonium was negatively associated with CaOx stone formation (unadjusted model, odds ratio 0.43[0.32-0.58], p&lt; 0.001 for CaOx). Urine calcium was positively associated with CaOx kidney stones (2.85 [2.11-3.92], p&lt;0.001). Similar results were obtained after adjusting for age, sex, and BMI. Replacing urine ammonium, pH, and phosphate with NAEC or ammonium and pH with AB score in our logistic regression models showed that NAEC and AB score are strongly associated with CaOx kidney stone formation.</p></sec><sec id="S4"><title>Conclusion</title><p id="P4">Ammonium excretion, NAEC and AB score are associated with the occurrence of CaOx kidney stones suggesting a potential role of proximal tubule dysfunction in their formation. CaP stone formers exhibit a disproportionately higher calcium excretion when acid excretion increases.</p></sec></abstract><kwd-group><kwd>nephrolithiasis</kwd><kwd>ammoniagenesis</kwd><kwd>acid-base</kwd></kwd-group></article-meta></front><body><sec id="S5" sec-type="intro"><title>Introduction</title><p id="P5">Kidney stone disease has a high prevalence worldwide, leading to significant morbidity and potentially increasing the risk of chronic kidney disease [<xref ref-type="bibr" rid="R1">1</xref>, <xref ref-type="bibr" rid="R2">2</xref>]. Dietary, lifestyle, genetic, and environmental factors are associated with higher risk of stone formation [<xref ref-type="bibr" rid="R3">3</xref>–<xref ref-type="bibr" rid="R5">5</xref>]. Yet, urine pH and supersaturation are the strongest factors underlying urine crystal formation [<xref ref-type="bibr" rid="R6">6</xref>]. The influence of pH on nephrolithiasis is further shown by the larger risk of kidney stone formation in patients with urine acidification defects, with this risk being reduced by alkali therapy (except in patients with urate stones) [<xref ref-type="bibr" rid="R7">7</xref>].</p><p id="P6">Acid-base status also influences the content of citrate in the urine, which impacts on the formation of calcium-containing kidney stones [<xref ref-type="bibr" rid="R8">8</xref>]. Metabolic acidosis and acidic urine pH increase citrate reabsorption in the kidney proximal tubules, while alkaline urine pH reduces citrate reabsorption [<xref ref-type="bibr" rid="R9">9</xref>]. However, how the renal capacity to excrete acid influences the incidence of common kidney stone types is not completely understood. Worcester et al. suggested that calcium phosphate (CaP) stone formers (SF) have a proximal tubule acidification defect while female CaOx SF have reduced intestinal alkali absorption, which could generate the acidic urine pH typically observed in this group (3).</p><p id="P7">Leveraging the extensive urine biochemistry profile available in the Swiss Kidney Stone Cohort, we tested whether urinary acid-base parameters, such as pH, ammonium, titratable acids, net acid excretion (NAE), and citrate were associated with CaOx and CaP stone formation. We assessed the kidney’s capacity of excreting acids by calculating net acid excretion capacity from the residuals of the relation between net acid excretion and urine pH and the recently published acid-base (AB) score [<xref ref-type="bibr" rid="R10">10</xref>].</p></sec><sec id="S6" sec-type="methods"><title>Methods</title><sec id="S7"><title>Swiss Kidney Stone cohort</title><p id="P8">The Swiss Kidney Stone cohort (SKSC, ClinicalTrials.gov, NCT01990027) is an investigator-initiated prospective, multicentric longitudinal, observational study in patients with kidney stones. The study is performed according to the current version of the Declaration of Helsinki, ICH-GCP, GEP, and Swiss law on human studies, and was approved by the Swiss Cantonal Ethics Committees [<xref ref-type="bibr" rid="R11">11</xref>]. Individuals with kidney stone disease (SF) were followed over 3 years to collect blood and urine samples and clinical data. This study analyzed baseline data collected at visit 2 (V2), which was performed 2 weeks after the screening visit. Patients had their last stone episode between 6 and 15 weeks prior to V2. A control cohort of individuals CT-proven free of kidney stones and calcifications has been recruited (NSF, n = 205).</p><p id="P9">SKSC included individuals with recurrent stone disease or specified risk factors [<xref ref-type="bibr" rid="R11">11</xref>]. The exclusion criteria for stone formers in SKSC were: age below 18 years old, no signed informed consent and inability to follow the study protocol. Here, we included only SF with stones classified as CaOx (n = 333) or CaP (n = 135). CaOx SF were defined as those with an average stone mineral composition consisting of &gt;50% calcium oxalate. Patients with &gt;50% CaP content were categorized as CaP stone formers. We excluded individuals with missing data on kidney stone type (n = 165), or urine pH, citrate, phosphate, magnesium, or oxalate (n = 125 SF and 11 NSF). We noticed that calculated bicarbonate and NAE were highly influenced by urine pH values above 7.5, which skewed the regression and correlation analyses. Therefore, 4 SF and 1 NSF with urine pH values above 7.5 were excluded from the analyses. Additional analyses were performed by excluding individuals who used supplements or medication with known effects on acid-base balance (<xref ref-type="supplementary-material" rid="SD2">Supplemental Table 1</xref>).</p></sec><sec id="S8"><title>Blood and urine data</title><p id="P10">In this study we only used urine collected under mineral oil (paraffin) containing thymol as a chemical preservative. 24h urine samples were analyzed for urine volume, Na<sup>+</sup>, K<sup>+</sup>, Cl<sup>−</sup>, Ca<sup>2+</sup>, inorganic phosphate (Pi), Mg<sup>2+</sup>, total protein, albumin, oxalate, citrate, creatinine, uric acid, urea, ammonium, pH, and sulfate. Blood was analyzed for Na<sup>+</sup>, K<sup>+</sup>, Cl<sup>−</sup>, Ca<sup>2+</sup>, Mg<sup>2+</sup>, albumin, phosphate, glucose, creatinine, urea, uric acid, parathyroid hormone, calcidiol (25-OH-vitamin D<sup>3</sup>), calcitriol (1,25-OH2-vitamin D<sup>3</sup>), intact FGF23, HbA1c, and lipids. A minor fraction of patients also had blood pH (n=148) assessed.</p></sec><sec id="S9"><title>Equations</title><p id="P11">Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI 2009 formula without the race coefficient [<xref ref-type="bibr" rid="R12">12</xref>]. NAEC was calculated from the residuals of the linear regression between urine pH and ammonium excretion as done in [<xref ref-type="bibr" rid="R13">13</xref>]. AB score was calculated as described in [<xref ref-type="bibr" rid="R10">10</xref>] (<xref ref-type="table" rid="T1">Table 1</xref>). Other equations were calculated similar to Ferraro et al [<xref ref-type="bibr" rid="R14">14</xref>] (<xref ref-type="table" rid="T1">Table 1</xref>).</p></sec><sec id="S10"><title>Statistical Analysis</title><p id="P12">Logistic regression models were performed with centralized data normalized to their standard deviations. Linearity between continuous covariates and the dependent variable was assessed via a component residual plot. Multicollinearity was evaluated by calculating variance inflation factor (VIF). Variables used in the logistic models were considered linear and without multicollinearity.</p><p id="P13">Pearson correlation coefficients were obtained for correlation analysis. To assess whether the correlation results are influenced by kidney stone type as a potential effect modifier, additional linear regression models were performed, incorporating kidney stone type as an interaction term.</p><p id="P14">Continuous data are shown as mean ± SD and skewed data as median + [25th percentile; 75th percentile]. Categorical data are shown as count number and % within-group. Odds ratio (OR) are shown as OR [95% confidence interval]. Multi-group comparisons were performed with ANOVA followed by Bonferroni correction. The used for all analyses was 0.05.</p><p id="P15">All data organization, cleaning, and transformation, and calculations of descriptive statistics, statistical analyses, and visualization were performed on the R environment [<xref ref-type="bibr" rid="R15">15</xref>] with Rstudio and using the following packages: car, dplyr, ggplot2, ggpubr, Hmisc, janitor, lubridate, rstatix, summarytools, <xref ref-type="table" rid="T1">table1</xref>.</p></sec></sec><sec id="S11" sec-type="results"><title>Results</title><p id="P16">We included 309 calcium oxalate (CaOx) and 28 calcium phosphate (CaP) stone formers (SF) and 193 non-stone formers (NSF) in this study (<xref ref-type="fig" rid="F1">Figure 1</xref>). CaOx SF were slightly older than NSF individuals and CaP SF. They were more often males, and had slightly higher BMI than NSF, besides similar baseline eGFR and showed lower calculated gastrointestinal alkali absorption levels (<xref ref-type="table" rid="T2">Table 2</xref>). Baseline blood and urinary parameters are summarized in <xref ref-type="supplementary-material" rid="SD2">Supplemental Tables 2 and Table 3</xref>. 24h urine excretion in CaOx and CaP SF was lower for citrate, oxalate, and potassium (<xref ref-type="table" rid="T3">Table 3</xref>), and in addition, CaOx SF exhibited a lower 24h urine volume, ammonium and magnesium excretion. In contrast, CaOx and CaP SF excreted more calcium (<xref ref-type="table" rid="T3">Table 3</xref>). Urine pH was more acidic in CaOx SF in comparison with NSFs.</p><p id="P17">Next, we tested whether urinary acid-base parameters were associated with the presence of CaOx or CaP stones in our patients. In addition, we included variables typically associated with kidney stone formation, such as urinary calcium and oxalate excretion. Urine magnesium is a relevant mediator [<xref ref-type="bibr" rid="R16">16</xref>] or confounder [<xref ref-type="bibr" rid="R17">17</xref>] in this model and was also included. We performed logistic regression models using urine ammonium, pH, citrate, phosphate, calcium, magnesium, and oxalate as independent variables (model 0). We also corrected this model using age, BMI, and sex as confounders given their potential effects both on exposure and outcome (model 1). According to model 0 for CaOx, holding all other independent variables constant, urine ammonium, pH, citrate, and calcium were significantly associated with the odds of having kidney stones (<xref ref-type="table" rid="T4">Table 4</xref>). Results remained largely consistent after adjusting for age, BMI, and sex, although urine pH appeared to have been partially reduced in effect size (<xref ref-type="supplementary-material" rid="SD2">Supplemental Table 3</xref>). Urinary ammonium had the lowest and urinary calcium the highest odds ratio for the association with CaOx occurrence in the adjusted logistic regression analysis. Given the low number of CaP SF in our cohort, logistic models did not perform well and data are not included.</p><p id="P18">Urine acid-base parameters were differentially affected in CaOx and CaP SF. We calculated net acid excretion capacity (NAEC) from the residuals of the regression analysis between NAE and urine pH [<xref ref-type="bibr" rid="R13">13</xref>] (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Considering that NAE and urine pH are strongly associated in healthy kidneys, NAEC provides an index of how much acid is excreted for a given urine pH. NAEC is reduced in CaOx SF (-1.74 ± 17.78) in relation to NSF (3.80 ± 17.87, p = 0.002). CaP SF showed values that were intermediate between the other two groups (0.63 ± 20.84, p = 1.0) (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Calculated titratable acidity was similar across all groups (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Recently, another approach has been proposed to analyze the relation between ammonium excretion and urine pH and was termed acid-base score (AB score) [<xref ref-type="bibr" rid="R10">10</xref>]. AB score was reduced in CaOx SF in comparison with NSF (20.37 ± 7.08 mmol/24h vs 23.14 ± 6.97, p &lt; 0.001) (<xref ref-type="fig" rid="F2">Figure 2D</xref>). Both NAEC and AB score demonstrate that CaOx SF have an acid excretion disorder.</p><p id="P19">Next, we performed logistic regression analysis for CaOx stone occurrence replacing urine ammonium, pH, and phosphate with NAEC. NAEC was associated with CaOx stone occurrence (OR 0.55 [0.42-0.71], p &lt; 0.001) (<xref ref-type="table" rid="T5">Table 5</xref>). AB score also associated with CaOx stone occurrence (OR 0.67 [0.53-0.83], p &lt; 0.001) in a model replacing urine ammonium and pH with AB score (<xref ref-type="table" rid="T6">Table 6</xref>). NAEC and AB score remained associated with CaOx occurrence after adjustment for age, BMI, and sex. While the odds ratio for NAEC were further reduced (OR 0.48 [0.36-0.64], p &lt; 0.001), AB score showed a weaker effect (OR 0.73 [0.58-0.93], p = 0.011) (<xref ref-type="supplementary-material" rid="SD2">Supplemental Tables 4 and 5</xref>).</p><p id="P20">Healthy kidneys increase the excretion of calcium in response to an acid load and calcium has been reported to be associated with urine pH and NAE [<xref ref-type="bibr" rid="R18">18</xref>, <xref ref-type="bibr" rid="R19">19</xref>]. We performed Pearson correlation analysis to detect whether these correlations were preserved in stone formers. We identified a dissipation of these associations in CaOx SF (<xref ref-type="fig" rid="F2">Figure 2E</xref>). The correlation between calcium excretion and urine pH was not strong but still significant in NSF individuals (R = -0.17, p-value = 0.017) and it was absent in CaOx SF (R= -0.07, p = 0.24) and CaP SF (R= -0.25, p = 0.19). Urine calcium was correlated with urine NAE, ammonium, and calculated TA in all three groups, but these correlations were stronger and steeper in CaP SF (<xref ref-type="fig" rid="F2">Figure 2F-H</xref>) as shown by higher Pearson correlation coefficients and steeper slopes (e.g., slope of NAE vs urine calcium: 0.11 vs 0.05, p = 0.005 for interaction with CaP stone formation).</p><p id="P21">Next, we tested whether differences in intestinal alkali absorption could explain the abnormal excretion patterns for calcium and ammonium in calcium SF. Although intestinal alkali absorption was reduced in CaOx and CaP SF (<xref ref-type="table" rid="T2">Table 2</xref>), its relation with urinary acid-base parameters and urine calcium was not significantly altered in SF (<xref ref-type="supplementary-material" rid="SD1">Supplemental figure 1</xref>).</p><p id="P22">We repeated the Pearson correlation analysis shown in <xref ref-type="fig" rid="F2">Figure 2</xref> but removing data from individuals who reported the use of supplements or medications with known effects on acid-base balance (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figures 2 and 3</xref>). Acid excretion capacity was similarly altered in this subpopulation when compared to individuals not excluded by supplement or medication intake. Moreover, we repeated the logistic regression analyses with this subpopulation. This analysis provided similar patterns to those reported in <xref ref-type="table" rid="T4">Tables 4</xref>-<xref ref-type="table" rid="T6">6</xref>, with ammonium and NAEC being strongly negatively associated with CaOx stones. Interestingly, AB score showed a weaker association with CaOx stone occurrence in this subpopulation (<xref ref-type="supplementary-material" rid="SD2">Supplemental Tables 10 and 11</xref>). Calcium remained positively associated with CaOx (<xref ref-type="supplementary-material" rid="SD2">Supplemental Tables 6-11</xref>). Therefore, the similar results before and after applying this exclusion criterion suggest that the pathomechanisms underlying calcium stone formation reported here are likely intrinsic to the tubular function of these patients.</p></sec><sec id="S12" sec-type="discussion"><title>Discussion</title><p id="P23">The main chemical determinants of urinary crystal formation are supersaturation, pH, and impurities [<xref ref-type="bibr" rid="R6">6</xref>]. Moreover, pH modulates different steps of crystal formation, such as supersaturation itself and nucleation [<xref ref-type="bibr" rid="R20">20</xref>]. While the contribution of urine pH to CaOx formation [<xref ref-type="bibr" rid="R21">21</xref>] is still unclear, CaP supersaturation increases abruptly between pH 6 and 7 [<xref ref-type="bibr" rid="R22">22</xref>] and an alkaline urine is one of the strongest determinants of CaP formation [<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R23">23</xref>]. In our cohort, CaOx SF showed a more acidic urine than NSF, but no difference was observed in CaP SF. Despite this alteration, urine pH was only weakly associated with CaOx formation in our logistic regression models, in agreement with another recent study (22). In contrast, other key acid-base variables, such as urine ammonium and citrate were strongly associated with CaOx kidney stones. Furthermore, CaOx SF showed reduced NAEC and AB scores, demonstrating a reduced acid excretion capacity in this population.</p><sec id="S13"><title>Lower acid excretion capacity associates with CaOx kidney stones</title><p id="P24">Impaired acid-base handling has been previously suggested as a potential contributor to calcium stone formation [<xref ref-type="bibr" rid="R24">24</xref>]. Worcester et al compared urine composition of CaOx and CaP SF in fasting and fed conditions. They observed that CaP SF in fed conditions had higher ammonium but lower citrate excretion accompanied by higher urine pH and suggested that this would derive from a proximal tubule defect. In our study, samples were collected over 24 hours while participants were eating their normal diet and ammonium excretion was lower in CaOx SF. Under the same condition, Worcester et al reported no significant differences.</p><p id="P25">Previously, we showed that mice lacking <italic>Gpr68</italic>, the proton-activated ovarian cancer G protein-coupled receptor 1 (OGR1), have a proton secretion defect in the proximal tubule [<xref ref-type="bibr" rid="R25">25</xref>]. These animals show a strong disruption of the associations between urine pH and urinary excretion of ammonium and calcium [<xref ref-type="bibr" rid="R19">19</xref>]. Interestingly, when oxalate nephropathy was induced with a high oxalate diet, these animals deposited more calcium oxalate crystals and tubular damage [<xref ref-type="bibr" rid="R26">26</xref>]. While the present work does not demonstrate causality, we hypothesize that a reduced capacity to excrete acid may be linked to a higher CaOx crystal deposition.</p></sec><sec id="S14"><title>Origin of the defect in CaOx stone formers</title><p id="P26">Worcester et al suggested that a more acidic urine pH in fed female CaOx SF would derive from lower gastrointestinal alkali absorption [<xref ref-type="bibr" rid="R24">24</xref>]. Likewise, we identified reduced intestinal alkali absorption in CaOx and CaP SF, suggesting that dietary factors might be involved in the acid-base disturbances observed in calcium stone formers. However, no differences were found among all groups in the association between GI alkali absorption and net acid or ammonium excretion, or urine pH. Alterations in ammonium and net acid excretion capacity suggest that kidneys are the site responsible for the observed defects. It is tempting to speculate that the proximal tubule is the segment responsible for this defect, based on the following considerations: 1) ammoniagenesis occurs in the proximal tubules, and while its excretion depends on processes downstream in the nephron, they ultimately depend on the capacity to acidify urine [<xref ref-type="bibr" rid="R27">27</xref>], which is apparently preserved in CaOx stone formers; 2) a proximal tubule defect in acid secretion is enough to generate a higher risk for CaOx crystal deposition [<xref ref-type="bibr" rid="R19">19</xref>, <xref ref-type="bibr" rid="R25">25</xref>, <xref ref-type="bibr" rid="R26">26</xref>]; 3) In this study, CaOx stone formers showed also reduced urine citrate excretion and the proximal tubule is the main site of citrate reabsorption.</p><p id="P27">Lower ammonium excretion was positively associated with CaOx kidney stone types. While NAE did not associate with CaOx stones occurrence (data not shown), urine pH showed a weak association with it after adjustment for age, BMI, and sex; NAEC, being the residuals of the linear regression of NAE and urine pH, offers information that pH, NAE, and ammonium excretion cannot provide individually. The defect in ammonium excretion is further illustrated by the lower AB score, which has also been shown to be associated with a higher risk for CKD progression [<xref ref-type="bibr" rid="R10">10</xref>]. It remains to be determined whether individuals with CKD and low AB score have a higher risk for CaOx kidney stone deposition.</p><p id="P28">The low sample size for CaP stone formers limited us to apply the same logistic analysis for this population. However, mean levels for urine ammonium and citrate were similar between CaOx and CaP stone formers. To further test whether NAE capacity is altered in calcium stone formers, NAE capacity should be assessed in individuals challenged with an acid load. A few studies have subjected stone formers to an acid load, either via NH<sub>4</sub>Cl intake or furosemide with fludrocortisone [<xref ref-type="bibr" rid="R28">28</xref>–<xref ref-type="bibr" rid="R30">30</xref>]. Incomplete renal tubular acidosis was identified in a minor proportion of CaP stone formers and probably cannot explain most of the cases [<xref ref-type="bibr" rid="R28">28</xref>, <xref ref-type="bibr" rid="R31">31</xref>].</p></sec><sec id="S15"><title>Exacerbated calcium excretion in CaP stone formers and dysregulated calcium excretion in CaOx stone formers</title><p id="P29">Hypercalciuria is a frequently observed feature in calcium stone formers [<xref ref-type="bibr" rid="R32">32</xref>]. Urine acidification increases calcium excretion and vice-versa [<xref ref-type="bibr" rid="R33">33</xref>–<xref ref-type="bibr" rid="R35">35</xref>]. In our study, we detected a weak negative association between urine pH and calcium excretion and a moderate positive association between NAE and calcium excretion in NSF. However, CaP SF exacerbated these interactions, in which calcium excretion was proportionally higher towards higher levels of acid excretion. These individuals showed both a higher Pearson correlation coefficient and a steeper slope when correlating both variables. CaOx SF showed an apparent disruption of the association between acid and calcium excretion despite also presenting higher calcium excretion levels in comparison with NSF. These results further demonstrate that calcium excretion is closely linked with acid excretion and that CaOx and CaP SF exhibit distinct dysregulations in the interactions between kidney calcium and acid handling.</p><p id="P30">Our study has some limitations. The low sample size for CaP stone formers may have prevented the detection of relevant associations between CaP stone formation and acid-base parameters. Titratable acidity and bicarbonate were calculated instead of measured, besides the worse performance of bicarbonate calculation when urine pH is high (i.e. above 7.5). However, in this study, calculated TA has an advantage over measured TA, as it is not affected by the precipitation of calcium phosphate [<xref ref-type="bibr" rid="R36">36</xref>]. Moreover, we did not include systemic acid-base status in our analysis given incomplete blood gas analysis data. We also did not stratify our cohort for sex to preserve statistical power. Yet, we adjusted all analyses for sex, which did not change outcomes. However, our study shows important strengths: extensive urinary biochemical data performed close to stone diagnosis, the validation of our control group by CT scan, and detailed medication history of patients.</p><p id="P31">In summary, the kidney’s capacity of excreting acid and its interaction with calcium excretion are differentially impaired in CaP and CaOx stone formers, which most probably reflects different tubular defects that increase the probability of stone formation.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary figures</label><media xlink:href="EMS199174-supplement-Supplementary_figures.pdf" mimetype="application" mime-subtype="pdf" id="d29aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary tables</label><media xlink:href="EMS199174-supplement-Supplementary_tables.pdf" mimetype="application" mime-subtype="pdf" id="d29aAcEcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Supplementary Figure 4</label><media xlink:href="EMS199174-supplement-Supplementary_Figure_4.pdf" mimetype="application" mime-subtype="pdf" id="d29aAcEdB" position="anchor"/></supplementary-material></sec></body><back><ack id="S16"><title>Acknowledgements</title><p>The Swiss Kidney Stone Cohort has been supported by the National Center of Competence in Research NCCR.CH financed by the Swiss National Science Foundation and the University of Zurich. CAW is also supported by the Swiss National Science Foundation (212303). DGF was supported by the Swiss National Science Foundation (grants # 33IC30-166785/1 and 320030-227578).</p></ack><fn-group><fn id="FN1" fn-type="conflict"><p id="P32"><bold>Conflict of Interest</bold></p><p id="P33">CAW reports honoraria from Kyowa Kirin, Medice, and Chugai outside this work. DGF served as a consultant for Otsuka, Alnylam, Boehringer Ingelheim and Kyowa Kirin, and received unrestricted research grants from Otsuka, Boehringer Ingelheim and CSL Vifor. AR received speaker fees from Alnylam, CSL Vifor, Boehringer Ingelheim and Forum für medizinische Fortbildung (FOMF) and support for travel expenses and attending meetings by Astellas, Boehringer Ingelheim and Salmon Pharma outside this work.</p></fn></fn-group><ref-list><ref id="R1"><label>[1]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rule</surname><given-names>AD</given-names></name><name><surname>Bergstralh</surname><given-names>EJ</given-names></name><name><surname>Melton</surname><given-names>LJ</given-names></name><etal/></person-group><article-title>Kidney Stones and the Risk for Chronic Kidney Disease</article-title><source>Clin J Am Soc Nephrol CJASN</source><year>2009</year><volume>4</volume><fpage>804</fpage><lpage>811</lpage><pub-id pub-id-type="pmcid">PMC2666438</pub-id><pub-id pub-id-type="pmid">19339425</pub-id><pub-id pub-id-type="doi">10.2215/CJN.05811108</pub-id></element-citation></ref><ref id="R2"><label>[2]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L-T</given-names></name><name><surname>Ali</surname><given-names>AE</given-names></name><name><surname>Jayachandran</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association between Kidney Stones and CKD: A Bidirectional Mendelian Randomization Study</article-title><source>J Am Soc Nephrol</source><year>2024</year><pub-id pub-id-type="pmid">39102294</pub-id></element-citation></ref><ref id="R3"><label>[3]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraro</surname><given-names>PM</given-names></name><name><surname>Taylor</surname><given-names>EN</given-names></name><name><surname>Gambaro</surname><given-names>G</given-names></name><etal/></person-group><article-title>Dietary and Lifestyle Risk Factors Associated with Incident Kidney Stones in Men and Women</article-title><source>J Urol</source><year>2017</year><volume>198</volume><fpage>858</fpage><lpage>863</lpage><pub-id pub-id-type="pmcid">PMC5599330</pub-id><pub-id pub-id-type="pmid">28365271</pub-id><pub-id pub-id-type="doi">10.1016/j.juro.2017.03.124</pub-id></element-citation></ref><ref id="R4"><label>[4]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldfarb</surname><given-names>DS</given-names></name><name><surname>Avery</surname><given-names>AR</given-names></name><name><surname>Beara-Lasic</surname><given-names>L</given-names></name><etal/></person-group><article-title>A Twin Study of Genetic Influences on Nephrolithiasis in Women and Men</article-title><source>Kidney Int Rep</source><year>2018</year><volume>4</volume><fpage>535</fpage><lpage>540</lpage><pub-id pub-id-type="pmcid">PMC6451147</pub-id><pub-id pub-id-type="pmid">30993229</pub-id><pub-id pub-id-type="doi">10.1016/j.ekir.2018.11.017</pub-id></element-citation></ref><ref id="R5"><label>[5]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maline</surname><given-names>GE</given-names></name><name><surname>Goldfarb</surname><given-names>DS</given-names></name></person-group><article-title>Climate change and kidney stones</article-title><source>CurrOpin NephrolHypertens</source><year>2024</year><volume>33</volume><fpage>89</fpage><pub-id pub-id-type="pmid">37725125</pub-id></element-citation></ref><ref id="R6"><label>[6]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinosa-Ortiz</surname><given-names>EJ</given-names></name><name><surname>Eisner</surname><given-names>BH</given-names></name><name><surname>Lange</surname><given-names>D</given-names></name><etal/></person-group><article-title>Current insights into the mechanisms and management of infection stones</article-title><source>Nat Rev Urol</source><year>2019</year><volume>16</volume><fpage>35</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">30470787</pub-id></element-citation></ref><ref id="R7"><label>[7]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sromicki</surname><given-names>J</given-names></name><name><surname>Kacl</surname><given-names>G</given-names></name><name><surname>Föhl</surname><given-names>M</given-names></name><etal/></person-group><article-title>Prospective long-term evaluation of incomplete distal renal tubular acidosis in idiopathic calcium nephrolithiasis diagnosed by low-dose NH4CL loading-gender prevalences and impact of alkali treatment</article-title><source>J Nephrol</source><year>2022</year><volume>35</volume><fpage>1619</fpage><lpage>1626</lpage><pub-id pub-id-type="pmcid">PMC9300500</pub-id><pub-id pub-id-type="pmid">34973150</pub-id><pub-id pub-id-type="doi">10.1007/s40620-021-01207-7</pub-id></element-citation></ref><ref id="R8"><label>[8]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adomako</surname><given-names>EA</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Sakhaee</surname><given-names>K</given-names></name><etal/></person-group><article-title>Urine pH and Citrate as Predictors of Calcium Phosphate Stone Formation</article-title><source>Kidney360</source><year>2023</year><volume>4</volume><fpage>1123</fpage><pub-id pub-id-type="pmcid">PMC10476682</pub-id><pub-id pub-id-type="pmid">37307531</pub-id><pub-id pub-id-type="doi">10.34067/KID.0000000000000184</pub-id></element-citation></ref><ref id="R9"><label>[9]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>S</given-names></name><name><surname>Hering-Smith</surname><given-names>K</given-names></name><name><surname>Hamm</surname><given-names>LL</given-names></name></person-group><article-title>Effect of pH on citrate reabsorption in the proximal convoluted tubule</article-title><source>Am J Physiol</source><year>1988</year><volume>255</volume><fpage>F301</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">2841871</pub-id></element-citation></ref><ref id="R10"><label>[10]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svendsen</surname><given-names>SL</given-names></name><name><surname>Rousing</surname><given-names>AQ</given-names></name><name><surname>Carlsen</surname><given-names>RK</given-names></name><etal/></person-group><article-title>A Urine pH-Ammonium Acid/Base Score and CKD Progression</article-title><source>J Am Soc Nephrol</source><year>2024</year><pub-id pub-id-type="pmid">39018119</pub-id></element-citation></ref><ref id="R11"><label>[11]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonny</surname><given-names>O</given-names></name><name><surname>Fuster</surname><given-names>D</given-names></name><name><surname>Seeger</surname><given-names>H</given-names></name><etal/></person-group><article-title>The Swiss Kidney Stone Cohort: A Longitudinal Multicentric, Observational Cohort to Study Course and Causes of Kidney Stone Disease in Switzerland</article-title><source>Kidney Blood Press Res</source><year>2023</year><volume>48</volume><fpage>194</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">36780886</pub-id></element-citation></ref><ref id="R12"><label>[12]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Stevens</surname><given-names>LA</given-names></name><name><surname>Schmid</surname><given-names>CH</given-names></name><etal/></person-group><article-title>A New Equation to Estimate Glomerular Filtration Rate</article-title><source>Ann Intern Med</source><year>2009</year><volume>150</volume><fpage>604</fpage><lpage>612</lpage><pub-id pub-id-type="pmcid">PMC2763564</pub-id><pub-id pub-id-type="pmid">19414839</pub-id><pub-id pub-id-type="doi">10.7326/0003-4819-150-9-200905050-00006</pub-id></element-citation></ref><ref id="R13"><label>[13]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkemeyer</surname><given-names>S</given-names></name><name><surname>Vormann</surname><given-names>J</given-names></name><name><surname>Günther</surname><given-names>ALB</given-names></name><etal/></person-group><article-title>Renal Net Acid Excretion Capacity Is Comparable in Prepubescence, Adolescence, and Young Adulthood but Falls with Aging</article-title><source>J Am GeriatrSoc</source><year>2008</year><volume>56</volume><fpage>1442</fpage><lpage>1448</lpage><pub-id pub-id-type="pmid">18808599</pub-id></element-citation></ref><ref id="R14"><label>[14]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraro</surname><given-names>PM</given-names></name><name><surname>Taylor</surname><given-names>EN</given-names></name><name><surname>Asplin</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Associations between Net Gastrointestinal Alkali Absorption, 24-Hour Urine Lithogenic Factors, and Kidney Stones</article-title><source>Clin J Am Soc Nephrol</source><year>2023</year><volume>18</volume><fpage>1068</fpage><pub-id pub-id-type="pmcid">PMC10564372</pub-id><pub-id pub-id-type="pmid">37256914</pub-id><pub-id pub-id-type="doi">10.2215/CJN.0000000000000195</pub-id></element-citation></ref><ref id="R15"><label>[15]</label><element-citation publication-type="web"><collab>R Development Core Team</collab><source>R: A Language and Environment for Statistical Computing</source><year>2011</year><comment><ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link></comment></element-citation></ref><ref id="R16"><label>[16]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Krieger</surname><given-names>NS</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Magnesium decreases urine supersaturation but not calcium oxalate stone formation in genetic hypercalciuric stone-forming rats</article-title><source>Nephron</source><year>2024</year><volume>1</volume><pub-id pub-id-type="pmcid">PMC11219255</pub-id><pub-id pub-id-type="pmid">38262368</pub-id><pub-id pub-id-type="doi">10.1159/000534495</pub-id></element-citation></ref><ref id="R17"><label>[17]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrè</surname><given-names>S</given-names></name><name><surname>Grange</surname><given-names>JS</given-names></name><name><surname>Adams-Huet Ms</surname><given-names>B</given-names></name><etal/></person-group><article-title>Effect of urine pH and magnesium on calcium oxalate saturation</article-title><source>Magnes Res</source><year>2017</year><volume>30</volume><fpage>107</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">29637896</pub-id></element-citation></ref><ref id="R18"><label>[18]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemann</surname><given-names>J</given-names><suffix>Jr</suffix></name></person-group><article-title>Relationship between Urinary Calcium and Net Acid Excretion as Determined by Dietary Protein and Potassium: A Review</article-title><source>Nephron</source><year>1998</year><volume>81</volume><fpage>18</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">9873210</pub-id></element-citation></ref><ref id="R19"><label>[19]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imenez Silva</surname><given-names>PH</given-names></name><name><surname>Katamesh-Benabbas</surname><given-names>C</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><etal/></person-group><article-title>The proton-activated ovarian cancer G protein-coupled receptor 1 (OGR1) is responsible for renal calcium loss during acidosis</article-title><source>Kidney /nt</source><year>2020</year><volume>97</volume><fpage>920</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">32173037</pub-id></element-citation></ref><ref id="R20"><label>[20]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibis</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>TW</given-names></name><name><surname>Penha</surname><given-names>FM</given-names></name><etal/></person-group><article-title>Nucleation kinetics of calcium oxalate monohydrate as a function of pH magnesium, and osteopontin concentration quantified with droplet microfluidics</article-title><source>Biomicrofluidics</source><year>2021</year><volume>15</volume><elocation-id>064103</elocation-id><pub-id pub-id-type="pmcid">PMC8610605</pub-id><pub-id pub-id-type="pmid">34853626</pub-id><pub-id pub-id-type="doi">10.1063/5.0063714</pub-id></element-citation></ref><ref id="R21"><label>[21]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>M</given-names></name></person-group><article-title>Urinary pH in calcium oxalate stone formers: does it matter?</article-title><source>J Bras Nefrol</source><year>2018</year><volume>40</volume><fpage>6</fpage><lpage>7</lpage><pub-id pub-id-type="pmcid">PMC6533969</pub-id><pub-id pub-id-type="pmid">29738024</pub-id><pub-id pub-id-type="doi">10.1590/1678-4685-JBN-2018-00010002</pub-id></element-citation></ref><ref id="R22"><label>[22]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worcester</surname><given-names>EM</given-names></name><name><surname>Coe</surname><given-names>FL</given-names></name></person-group><article-title>Clinical Practice Calcium Kidney Stones</article-title><source>N Engl J Med</source><year>2010</year><volume>363</volume><fpage>954</fpage><lpage>963</lpage><pub-id pub-id-type="pmcid">PMC3192488</pub-id><pub-id pub-id-type="pmid">20818905</pub-id><pub-id pub-id-type="doi">10.1056/NEJMcp1001011</pub-id></element-citation></ref><ref id="R23"><label>[23]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parks</surname><given-names>JH</given-names></name><name><surname>Coward</surname><given-names>M</given-names></name><name><surname>Coe</surname><given-names>FL</given-names></name></person-group><article-title>Correspondence between stone composition and urine supersaturation in nephrolithiasis</article-title><source>Kidney Int</source><year>1997</year><volume>51</volume><fpage>894</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">9067927</pub-id></element-citation></ref><ref id="R24"><label>[24]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worcester</surname><given-names>EM</given-names></name><name><surname>Bergsland</surname><given-names>KJ</given-names></name><name><surname>Gillen</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Evidence for disordered acid-base handling in calcium stone-forming patients</article-title><source>Am J Physiol-Ren Physiol</source><year>2020</year><volume>318</volume><fpage>F363</fpage><lpage>F374</lpage><pub-id pub-id-type="pmcid">PMC7052659</pub-id><pub-id pub-id-type="pmid">31790303</pub-id><pub-id pub-id-type="doi">10.1152/ajprenal.00400.2019</pub-id></element-citation></ref><ref id="R25"><label>[25]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohebbi</surname><given-names>N</given-names></name><name><surname>Benabbas</surname><given-names>C</given-names></name><name><surname>Vidal</surname><given-names>S</given-names></name><etal/></person-group><article-title>The Proton-activated G Protein Coupled Receptor OGR1 Acutely Regulates the Activity of Epithelial Proton Transport Proteins</article-title><source>Cell Physiol Biochem</source><year>2012</year><volume>29</volume><fpage>313</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">22508039</pub-id></element-citation></ref><ref id="R26"><label>[26]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yassini</surname><given-names>N</given-names></name><name><surname>Sprenger</surname><given-names>J</given-names></name><name><surname>Pastor Arroyo</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Ovarian cancer G protein-coupled receptor 1 deficiency exacerbates crystal deposition and kidney injury in oxalate nephropathy in female mice</article-title><source>Clin Sci Land Engl 1979</source><year>2023</year><volume>137</volume><fpage>1013</fpage><lpage>1025</lpage><pub-id pub-id-type="pmid">37431800</pub-id></element-citation></ref><ref id="R27"><label>[27]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgeois</surname><given-names>S</given-names></name><name><surname>Houillier</surname><given-names>P</given-names></name></person-group><article-title>State of knowledge on ammonia handling by the kidney</article-title><source>Pflüg Arch-EurJ Physiol</source><year>2024</year><volume>476</volume><fpage>517</fpage><lpage>531</lpage><pub-id pub-id-type="pmcid">PMC11006756</pub-id><pub-id pub-id-type="pmid">38448728</pub-id><pub-id pub-id-type="doi">10.1007/s00424-024-02940-1</pub-id></element-citation></ref><ref id="R28"><label>[28]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhayat</surname><given-names>NA</given-names></name><name><surname>Gradwell</surname><given-names>MW</given-names></name><name><surname>Pathare</surname><given-names>G</given-names></name><etal/></person-group><article-title>Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers</article-title><source>Clin J Am Soc Nephrol</source><year>2017</year><volume>12</volume><fpage>1507</fpage><pub-id pub-id-type="pmcid">PMC5586565</pub-id><pub-id pub-id-type="pmid">28775126</pub-id><pub-id pub-id-type="doi">10.2215/CJN.01320217</pub-id></element-citation></ref><ref id="R29"><label>[29]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakhaee</surname><given-names>K</given-names></name><name><surname>Adams-Huet</surname><given-names>B</given-names></name><name><surname>Moe</surname><given-names>OW</given-names></name><etal/></person-group><article-title>Pathophysiologic basis for normouricosuric uric acid nephrolithiasis</article-title><source>Kidney Int</source><year>2002</year><volume>62</volume><fpage>971</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">12164880</pub-id></element-citation></ref><ref id="R30"><label>[30]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimerà</surname><given-names>J</given-names></name><name><surname>Martínez</surname><given-names>A</given-names></name><name><surname>Tubau</surname><given-names>V</given-names></name><etal/></person-group><article-title>Prevalence of distal renal tubular acidosis in patients with calcium phosphate stones</article-title><source>World J Urol</source><year>2020</year><volume>38</volume><fpage>789</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">31079188</pub-id></element-citation></ref><ref id="R31"><label>[31]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gault</surname><given-names>MH</given-names></name><name><surname>Chafe</surname><given-names>LL</given-names></name><name><surname>Morgan</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Comparison of Patients with Idiopathic Calcium Phosphate and Calcium Oxalate Stones</article-title><source>Medicine (Baltimore)</source><year>1991</year><volume>70</volume><fpage>345</fpage><pub-id pub-id-type="pmid">1956278</pub-id></element-citation></ref><ref id="R32"><label>[32]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coe</surname><given-names>FL</given-names></name><name><surname>Worcester</surname><given-names>EM</given-names></name><name><surname>Evan</surname><given-names>AP</given-names></name></person-group><article-title>Idiopathic hypercalciuria and formation of calcium renal stones</article-title><source>Nat Rev Nephrol</source><year>2016</year><volume>12</volume><fpage>519</fpage><lpage>533</lpage><pub-id pub-id-type="pmcid">PMC5837277</pub-id><pub-id pub-id-type="pmid">27452364</pub-id><pub-id pub-id-type="doi">10.1038/nrneph.2016.101</pub-id></element-citation></ref><ref id="R33"><label>[33]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stacy</surname><given-names>BD</given-names></name><name><surname>Wilson</surname><given-names>BW</given-names></name></person-group><article-title>Acidosis and hypercalciuria: renal mechanisms affecting calcium magnesium and sodium excretion in the sheep</article-title><source>J Physiol</source><year>1970</year><volume>210</volume><fpage>549</fpage><lpage>564</lpage><pub-id pub-id-type="pmcid">PMC1395617</pub-id><pub-id pub-id-type="pmid">5499811</pub-id><pub-id pub-id-type="doi">10.1113/jphysiol.1970.sp009226</pub-id></element-citation></ref><ref id="R34"><label>[34]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijenhuis</surname><given-names>T</given-names></name><name><surname>Renkema</surname><given-names>KY</given-names></name><name><surname>Hoenderop</surname><given-names>JGJ</given-names></name><etal/></person-group><article-title>Acid-Base Status Determines the Renal Expression of Ca2+ and Mg2+ Transport Proteins</article-title><source>J Am Soc Nephrol</source><year>2006</year><volume>17</volume><fpage>617</fpage><lpage>626</lpage><pub-id pub-id-type="pmid">16421227</pub-id></element-citation></ref><ref id="R35"><label>[35]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renkema</surname><given-names>KY</given-names></name><name><surname>Velic</surname><given-names>A</given-names></name><name><surname>Dijkman</surname><given-names>HB</given-names></name><etal/></person-group><article-title>The Calcium-Sensing Receptor Promotes Urinary Acidification to Prevent Nephrolithiasis</article-title><source>J Am Soc Nephrol</source><year>2009</year><volume>20</volume><fpage>1705</fpage><lpage>1713</lpage><pub-id pub-id-type="pmcid">PMC2723980</pub-id><pub-id pub-id-type="pmid">19470676</pub-id><pub-id pub-id-type="doi">10.1681/ASN.2008111195</pub-id></element-citation></ref><ref id="R36"><label>[36]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kok</surname><given-names>DJ</given-names></name><name><surname>Poindexter</surname><given-names>J</given-names></name><name><surname>Pak</surname><given-names>CYC</given-names></name><etal/></person-group><article-title>Calculation of titratable acidity from urinary stone risk factors</article-title><source>Kidney Int</source><year>1993</year><volume>44</volume><fpage>120</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">8355452</pub-id></element-citation></ref></ref-list></back><floats-group><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Key learning points</title></caption><sec id="S17"><title>What was known</title><p>Urine pH is a strong determinant in the formation of various urologically relevant crystals. Impaired urine acidification capacity has been observed in individuals who form calcium phosphate and uric acid stones.</p></sec><sec id="S18"><title>This study adds</title><p>When compared to non-stone formers, calcium oxalate stone formers are marked by a reduced capacity of excreting acids when urine pH becomes more acidic.</p></sec><sec id="S19"><title>Potential impact</title><p>The calculation of net acid excretion capacity and acid-base score are novel tools to identify those under potential higher risk of developing calcium oxalate stones.</p></sec></boxed-text><fig id="F1" position="float"><label>Figure 1</label><caption><title>Flow chart of the studied population derived from the Swiss Kidney Stone Cohort. CaOx = calcium oxalate, CaP = calcium phosphate, and NSF = non-stone former.</title></caption><graphic xlink:href="EMS199174-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Acid excretion capacity is disturbed in CaOx stone formers (SF) and acid-dependent calcium excretion is exacerbated in CaP SF.</title><p>(A) Pearson correlation analysis between urine pH and net acid excretion (NAE). (B-D) Violin plots showing median and 25th and 75th percentile of (B) NAE capacity, (C) calculated titratable acidity (TA), and (D) acid-base (AB) score. (E-H) Pearson correlation analysis between urine pH and urine calcium (E), NAE and urine calcium (F), urine ammonium and calcium (G), and calculated TA and urine calcium (H). Blue dots = non stone formers (NSF), orange dots = CaOx SF, black dots = CaP SF. R = Pearson correlation coefficient and p = p-value associated with this correlation. α = 0.05.</p></caption><graphic xlink:href="EMS199174-f002"/><p>Crea – creatinine, P– phosphorus, K – potassium Ca –calcium, Mg – magnesium.</p></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Equations used in this study. U before an abbreviation indicates Urine.</title></caption><table frame="box" rules="all"><tbody><tr><td align="left" valign="top">Titratable acidity</td><td align="left" valign="top"><inline-formula><mml:math id="M1"><mml:mrow><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.8</mml:mn><mml:mo>*</mml:mo><mml:mtext> UP </mml:mtext><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>U</mml:mi><mml:mi>p</mml:mi><mml:mi>H</mml:mi><mml:mo>−</mml:mo><mml:mn>6.8</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>*</mml:mo><mml:mfrac><mml:mrow><mml:mtext> UP </mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>U</mml:mi><mml:mi>p</mml:mi><mml:mi>H</mml:mi><mml:mo>−</mml:mo><mml:mn>6.8</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"><mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mn>0.996</mml:mn><mml:mo>*</mml:mo><mml:mtext> UCrea </mml:mtext><mml:mo>−</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>U</mml:mi><mml:mi>p</mml:mi><mml:mi>H</mml:mi><mml:mo>−</mml:mo><mml:mn>4.92</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:mo>*</mml:mo><mml:mfrac><mml:mrow><mml:mtext> UCrea </mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>U</mml:mi><mml:mi>p</mml:mi><mml:mi>H</mml:mi><mml:mo>−</mml:mo><mml:mn>4.92</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow><mml:mo>]</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></inline-formula></td></tr><tr><td align="left" valign="top">Estimated bicarbonate</td><td align="left" valign="top">1.2×10(UpH–6.1) 1.2 * 10<sup>(UPH-6.1)</sup></td></tr><tr><td align="left" valign="top">Renal net acid excretion</td><td align="left" valign="top">Ammonium+ titratable acidity – estimated bicarbonate (all in mmol/min)</td></tr><tr><td align="left" valign="top">Net gastrointestinal alkali absorption</td><td align="left" valign="top">(UK+ UCa + UMg) – UP) (all in mEq/min)</td></tr><tr><td align="left" valign="top">AB score</td><td align="left" valign="top"><inline-formula><mml:math id="M2"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>log</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mtext>UNH</mml:mtext></mml:mrow><mml:mrow><mml:msup><mml:mn>4</mml:mn><mml:mo>+</mml:mo></mml:msup></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>*</mml:mo><mml:msup><mml:mrow><mml:mtext>UpH</mml:mtext></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>3.6</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow><mml:mrow><mml:mn>40</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></inline-formula></td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Baseline characteristics.</title><p>Categorical data are reported as count and percentage in relation to each group’s total sample size and continuous data as mean ± SD. Parameters with missing data have their sample size (n) shown next to the mean or median value of each group. Gl = gastrointestinal.</p></caption><table frame="box" rules="rows"><thead><tr style="background-color:#EEECE1"><th align="center" valign="top" colspan="4"><styled-content style="color:#FFFFFF">Baseline characteristics</styled-content></th></tr><tr><th align="center" valign="top"/><th align="center" valign="top">NSF (N=193)</th><th align="center" valign="top">CaOx (N=309)</th><th align="center" valign="top">CaP (N=28)</th></tr></thead><tbody><tr><td align="center" valign="top">Sex (Female)</td><td align="center" valign="top">84 (43.5%)</td><td align="center" valign="top">89 (28.8%)</td><td align="center" valign="top">18 (64.3%)</td></tr><tr><td align="center" valign="top">Age (years)</td><td align="center" valign="top">43.0 ± 13.6</td><td align="center" valign="top">46.4 ± 14.3</td><td align="center" valign="top">44.3 ± 14.4</td></tr><tr><td align="center" valign="top">BMI (kg/m<sup>2</sup>)</td><td align="center" valign="top">25.0 ±4.12</td><td align="center" valign="top">26.9 ±4.66</td><td align="center" valign="top">26.4 ± 5.73</td></tr><tr><td align="center" valign="top">Weight (kg)</td><td align="center" valign="top">75.7 ± 15.1</td><td align="center" valign="top">80.7 ± 16.4</td><td align="center" valign="top">74.7 ± 21.2</td></tr><tr><td align="center" valign="top">eGFR by CKD-EPI (ml/min per 1.73m2)</td><td align="center" valign="top">97.3 ± 16.1</td><td align="center" valign="top">96.8 ± 18.5</td><td align="center" valign="top">98.9 ± 16.8</td></tr><tr><td align="center" valign="top">GI alkali absorption (mEq/min)</td><td align="center" valign="top">29.6 ± 23.7</td><td align="center" valign="top">20.8 ± 15.6</td><td align="center" valign="top">21.0 ± 11.8</td></tr><tr><td align="center" valign="top">Hypertension</td><td align="center" valign="top">18 (9.4%), n =192</td><td align="center" valign="top">69 (22.3%), n = 307</td><td align="center" valign="top">9 (32.1%)</td></tr><tr><td align="center" valign="top">Diabetes type 1</td><td align="center" valign="top">0 (0%), n = 192</td><td align="center" valign="top">1 (0.3%), n = 305</td><td align="center" valign="top">0 (0.0%)</td></tr><tr><td align="center" valign="top">type 2</td><td align="center" valign="top">3 (1.6%), n = 192</td><td align="center" valign="top">28 (9.1%), 305</td><td align="center" valign="top">2 (7.1%)</td></tr><tr><td align="center" valign="top">Dyslipidemia</td><td align="center" valign="top">22 (11.5%), n = 192</td><td align="center" valign="top">41 (13.3%), n = 258</td><td align="center" valign="top">1 (3.6%), n = 25</td></tr><tr><td align="center" valign="top">Gout</td><td align="center" valign="top">2 (1.0%), n = 192</td><td align="center" valign="top">6 (1.9%), n = 305</td><td align="center" valign="top">1 (3.6%)</td></tr><tr><td align="center" valign="top">Smoker</td><td align="center" valign="top">43 (22.4%), n = 190</td><td align="center" valign="top">85 (27.6%), n = 301</td><td align="center" valign="top">5 (17.9%)</td></tr><tr><td align="center" valign="top">Ex-smoker</td><td align="center" valign="top">26 (13.5%), n = 190</td><td align="center" valign="top">38 (12.3%), n = 301</td><td align="center" valign="top">2 (7.1%)</td></tr><tr><td align="center" valign="top">Osteoporosis</td><td align="center" valign="top">5 (2.6%), n = 189</td><td align="center" valign="top">8 (2.6%), n = 232</td><td align="center" valign="top">0 (0.0%), n = 22</td></tr><tr><td align="center" valign="top">Fractures</td><td align="center" valign="top">96 (50.0%), n = 191</td><td align="center" valign="top">75 (24.3%), n = 296</td><td align="center" valign="top">4 (14.3%), n = 26</td></tr><tr><td align="center" valign="top">Immobilization</td><td align="center" valign="top">14 (7.3%), n = 180</td><td align="center" valign="top">15 (4.9%), n = 249</td><td align="center" valign="top">3 (10.7%), n = 23</td></tr><tr><td align="center" valign="top">Kidney stones in the family</td><td align="center" valign="top">29 (15.1%), n = 187</td><td align="center" valign="top">144 (46.4%), n = 305</td><td align="center" valign="top">14 (50.0%), n = 27</td></tr><tr><td align="center" valign="top">Kidney transplantation</td><td align="center" valign="top">1 (0.5%), n = 185</td><td align="center" valign="top">0 (0%), n = 302</td><td align="center" valign="top">1 (3.6%)</td></tr><tr><td align="center" valign="top">Pyelonephritis in the past</td><td align="center" valign="top">7 (3.6%)</td><td align="center" valign="top">48 (15.5%)</td><td align="center" valign="top">11 (39.3%)</td></tr><tr><td align="center" valign="top">Nephrocalcinosis</td><td align="center" valign="top">0 (0%), n = 191</td><td align="center" valign="top">19 (6.1%), n = 256</td><td align="center" valign="top">3 (10.7%), n = 25</td></tr><tr><td align="center" valign="top">Inflammatory bowel diseases</td><td align="center" valign="top">2 (1.0%), n = 189</td><td align="center" valign="top">17 (5.5%), n = 304</td><td align="center" valign="top">2 (7.1%)</td></tr><tr><td align="center" valign="top">Gastric bypass</td><td align="center" valign="top">2 (1.0%), n = 190</td><td align="center" valign="top">20 (6.5%), n = 304</td><td align="center" valign="top">0 (0.0%)</td></tr><tr><td align="center" valign="top">Vegetarian</td><td align="center" valign="top">16 (8.3%)</td><td align="center" valign="top">10 (3.2%)</td><td align="center" valign="top">1 (3.6%)</td></tr><tr><td align="center" valign="top">Lactose-free</td><td align="center" valign="top">9 (4.7%)</td><td align="center" valign="top">8 (2.6%)</td><td align="center" valign="top">0 (0%)</td></tr><tr><td align="center" valign="top">Vegan</td><td align="center" valign="top">2 (1.0%)</td><td align="center" valign="top">0 (0%)</td><td align="center" valign="top">0 (0%)</td></tr><tr><td align="center" valign="top">Other diets</td><td align="center" valign="top">15 (7.8%)</td><td align="center" valign="top">10 (3.2%)</td><td align="center" valign="top">3 (10.7%)</td></tr><tr><td align="center" valign="top">Supplements and vitamins</td><td align="center" valign="top">64 (33.3%), n =188</td><td align="center" valign="top">67 (21.7%), n = 250</td><td align="center" valign="top">8 (28.6%), n = 21</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3</label><caption><title>Urine parameters in SF and NSF individuals.</title><p>Baseline urine data are shown as mean ± SD and continuous skewed data as median [25<sup>th</sup> percentile; 75<sup>th</sup> percentile]. Parameters with missing data have their sample size (n) shown next to the mean or median value of each group. NAE = net acid excretion.</p></caption><table frame="box" rules="rows"><thead><tr style="background-color:#EEECE1"><th align="center" valign="top" colspan="4"><styled-content style="color:#FFFFFF">Urine parameters</styled-content></th></tr><tr><th align="center" valign="top"/><th align="center" valign="top">NSF (N=193)</th><th align="center" valign="top">CaOx (N=309)</th><th align="center" valign="top">CaP (N=28)</th></tr></thead><tbody><tr><td align="center" valign="top">Urine volume (l/24h)</td><td align="center" valign="top">2.10 ± 0.84</td><td align="center" valign="top">1.81 ± 0.77</td><td align="center" valign="top">2.04 ± 0.67</td></tr><tr><td align="center" valign="top">pH</td><td align="center" valign="top">6.04 ± 0.50</td><td align="center" valign="top">5.92 ± 0.51</td><td align="center" valign="top">5.97 ± 0.50</td></tr><tr><td align="center" valign="top">Bicarbonate (mmol/24h)</td><td align="center" valign="top">2.27 [0.886, 4.47]</td><td align="center" valign="top">1.36 [0.457, 3.57]</td><td align="center" valign="top">1.51 [1.06, 3.84]</td></tr><tr><td align="center" valign="top">Ammonium (mmol/24h)</td><td align="center" valign="top">28.70 ± 12.45</td><td align="center" valign="top">24.66 ± 11.84</td><td align="center" valign="top">25.63 ± 14.02</td></tr><tr><td align="center" valign="top">Citrate (mmol/24h)</td><td align="center" valign="top">3.39 ± 1.39</td><td align="center" valign="top">2.79 ± 1.35</td><td align="center" valign="top">2.63 ± 1.46</td></tr><tr><td align="center" valign="top">Sulfate (mmol/24h)</td><td align="center" valign="top">20.24 ±9.00</td><td align="center" valign="top">18.72 ± 7.93, n = 174</td><td align="center" valign="top">18.56 ±8.22, n = 14</td></tr><tr><td align="center" valign="top">Urea (mmol/24h)</td><td align="center" valign="top">369.91 ± 137.76</td><td align="center" valign="top">349.08 ± 148.77</td><td align="center" valign="top">353.83 ± 172.77</td></tr><tr><td align="center" valign="top">Sodium (mmol/24h)</td><td align="center" valign="top">154.60 ± 65.20</td><td align="center" valign="top">158.58 ± 71.38</td><td align="center" valign="top">159.49 ± 89.35</td></tr><tr><td align="center" valign="top">Potassium (mmol/24h)</td><td align="center" valign="top">74.95 ± 35.69</td><td align="center" valign="top">59.43 ± 26.30</td><td align="center" valign="top">57.93 ± 25.18</td></tr><tr><td align="center" valign="top">Chloride (mmol/24h)</td><td align="center" valign="top">141.82 ± 67.59</td><td align="center" valign="top">145.58 ± 66.69</td><td align="center" valign="top">182.68 ± 223.37</td></tr><tr><td align="center" valign="top">Calcium (mmol/24h)</td><td align="center" valign="top">4.15 [2.63, 5.71]</td><td align="center" valign="top">5.50 [3.69, 7.54]</td><td align="center" valign="top">5.43 [3.72, 9.42]</td></tr><tr><td align="center" valign="top">Inorganic phosphate (mmol/24h)</td><td align="center" valign="top">27.56 ± 11.19</td><td align="center" valign="top">26.97 ± 11.01</td><td align="center" valign="top">26.94 ± 14.76</td></tr><tr><td align="center" valign="top">Magnesium (mmol/24h)</td><td align="center" valign="top">4.13 ± 1.52</td><td align="center" valign="top">3.83 ± 1.67</td><td align="center" valign="top">3.72 ± 1.68</td></tr><tr><td align="center" valign="top">Oxalate (mmol/24h)</td><td align="center" valign="top">0.44 ± 0.28</td><td align="center" valign="top">0.33 ± 0.34</td><td align="center" valign="top">0.29 ± 0.14</td></tr><tr><td align="center" valign="top">Albumin (mmol/24h)</td><td align="center" valign="top">2.90 [2.00, 5.46]</td><td align="center" valign="top">5.95 [2.77, 12.2], n = 307</td><td align="center" valign="top">8.80 [2.63, 16.6], n = 27</td></tr><tr><td align="center" valign="top">Protein (g/24h)</td><td align="center" valign="top">0.11 ± 0.04</td><td align="center" valign="top">0.12 ± 0.08, n = 308</td><td align="center" valign="top">0.14 ± 0.11</td></tr><tr><td align="center" valign="top">Creatinine (mmol/24h)</td><td align="center" valign="top">13.05 ± 4.48</td><td align="center" valign="top">12.77 ± 4.50</td><td align="center" valign="top">11.54 ± 4.44</td></tr><tr><td align="center" valign="top">Titratable acids (mmol/24h)</td><td align="center" valign="top">18.40 ± 9.71</td><td align="center" valign="top">19.01 ± 9.43</td><td align="center" valign="top">18.82 ± 12.85</td></tr><tr><td align="center" valign="top">Net acid excretion (mmol/24h)</td><td align="center" valign="top">42.50 ± 23.75</td><td align="center" valign="top">40.61 ± 21.06</td><td align="center" valign="top">41.26 ± 25.96</td></tr></tbody></table></table-wrap><table-wrap id="T4" position="float" orientation="portrait"><label>Table 4</label><caption><title>Logistic regression model 0 with CaOx stone formation as dependent variable.</title><p>OR = odds ratio. The p-values were obtained from a Wald test with α = 0.05.</p></caption><table frame="box" rules="rows"><thead><tr style="background-color:#EEECE1"><th align="center" valign="top"><styled-content style="color:#FFFFFF">Urine parameter</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">estimate</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">Std error</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">statistic</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">p-value</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">OR</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">2.50%</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">97.50%</styled-content></th></tr></thead><tbody><tr><td align="center" valign="top">(Intercept)</td><td align="center" valign="top">0.60</td><td align="center" valign="top">0.11</td><td align="center" valign="top">5.599</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">1.83</td><td align="center" valign="top">1.48</td><td align="center" valign="top">2.27</td></tr><tr><td align="center" valign="top">Ammonium</td><td align="center" valign="top">-0.84</td><td align="center" valign="top">0.16</td><td align="center" valign="top">-5.403</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">0.43</td><td align="center" valign="top">0.32</td><td align="center" valign="top">0.58</td></tr><tr><td align="center" valign="top">pH</td><td align="center" valign="top">-0.37</td><td align="center" valign="top">0.11</td><td align="center" valign="top">-3.297</td><td align="center" valign="top">0.001</td><td align="center" valign="top">0.69</td><td align="center" valign="top">0.56</td><td align="center" valign="top">0.86</td></tr><tr><td align="center" valign="top">Citrate</td><td align="center" valign="top">-0.52</td><td align="center" valign="top">0.12</td><td align="center" valign="top">-4.373</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">0.60</td><td align="center" valign="top">0.47</td><td align="center" valign="top">0.75</td></tr><tr><td align="center" valign="top">Phosphate</td><td align="center" valign="top">0.23</td><td align="center" valign="top">0.15</td><td align="center" valign="top">1.51</td><td align="center" valign="top">0.131</td><td align="center" valign="top">1.26</td><td align="center" valign="top">0.93</td><td align="center" valign="top">1.72</td></tr><tr><td align="center" valign="top">Calcium</td><td align="center" valign="top">1.05</td><td align="center" valign="top">0.16</td><td align="center" valign="top">6.654</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">2.85</td><td align="center" valign="top">2.11</td><td align="center" valign="top">3.92</td></tr><tr><td align="center" valign="top">Magnesium</td><td align="center" valign="top">-0.28</td><td align="center" valign="top">0.15</td><td align="center" valign="top">-1.882</td><td align="center" valign="top">0.060</td><td align="center" valign="top">0.76</td><td align="center" valign="top">0.57</td><td align="center" valign="top">1.01</td></tr><tr><td align="center" valign="top">Oxalate</td><td align="center" valign="top">-0.19</td><td align="center" valign="top">0.15</td><td align="center" valign="top">-1.275</td><td align="center" valign="top">0.202</td><td align="center" valign="top">0.82</td><td align="center" valign="top">0.60</td><td align="center" valign="top">1.10</td></tr></tbody></table></table-wrap><table-wrap id="T5" position="float" orientation="portrait"><label>Table 5</label><caption><title>Logistic regression model 0 with CaOx stone formation as dependent variable and NAEC replacing ammonium, pH, and phosphate.</title><p>OR = odds ratio. The p-values were obtained from a Wald test with α = 0.05.</p></caption><table frame="box" rules="rows"><thead><tr style="background-color:#EEECE1"><th align="center" valign="top"><styled-content style="color:#FFFFFF">Urine parameter</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">estimate</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">Std error</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">statistic</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">p-value</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">OR</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">2.50%</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">97.50%</styled-content></th></tr></thead><tbody><tr><td align="center" valign="top">(Intercept)</td><td align="center" valign="top">0.59</td><td align="center" valign="top">0.11</td><td align="center" valign="top">5.606</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">1.81</td><td align="center" valign="top">1.48</td><td align="center" valign="top">2.24</td></tr><tr><td align="center" valign="top">NAEC</td><td align="center" valign="top">-0.60</td><td align="center" valign="top">0.13</td><td align="center" valign="top">-4.531</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">0.55</td><td align="center" valign="top">0.42</td><td align="center" valign="top">0.71</td></tr><tr><td align="center" valign="top">Citrate</td><td align="center" valign="top">-0.47</td><td align="center" valign="top">0.11</td><td align="center" valign="top">-4.167</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">0.62</td><td align="center" valign="top">0.49</td><td align="center" valign="top">0.77</td></tr><tr><td align="center" valign="top">Calcium</td><td align="center" valign="top">1.08</td><td align="center" valign="top">0.15</td><td align="center" valign="top">6.953</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">2.93</td><td align="center" valign="top">2.19</td><td align="center" valign="top">4.01</td></tr><tr><td align="center" valign="top">Magnesium</td><td align="center" valign="top">-0.21</td><td align="center" valign="top">0.14</td><td align="center" valign="top">-1.549</td><td align="center" valign="top">0.122</td><td align="center" valign="top">0.81</td><td align="center" valign="top">0.61</td><td align="center" valign="top">1.06</td></tr><tr><td align="center" valign="top">Oxalate</td><td align="center" valign="top">-0.27</td><td align="center" valign="top">0.15</td><td align="center" valign="top">-1.836</td><td align="center" valign="top">0.066</td><td align="center" valign="top">0.76</td><td align="center" valign="top">0.56</td><td align="center" valign="top">1.01</td></tr></tbody></table></table-wrap><table-wrap id="T6" position="float" orientation="portrait"><label>Table 6</label><caption><title>Logistic regression model 0 with CaOx stone formation as dependent variable and AB score replacing urine ammonium and pH.</title><p>OR = odds ratio. The p-values were obtained from a Wald test with α = 0.05.</p></caption><table frame="box" rules="rows"><thead><tr style="background-color:#EEECE1"><th align="center" valign="top"><styled-content style="color:#FFFFFF">Urine parameter</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">estimate</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">Std error</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">statistic</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">p-value</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">OR</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">2.50%</styled-content></th><th align="center" valign="top"><styled-content style="color:#FFFFFF">97.50%</styled-content></th></tr></thead><tbody><tr><td align="center" valign="top">(Intercept)</td><td align="center" valign="top">0.59</td><td align="center" valign="top">0.10</td><td align="center" valign="top">5.601</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">1.80</td><td align="center" valign="top">1.47</td><td align="center" valign="top">2.21</td></tr><tr><td align="center" valign="top">AB score</td><td align="center" valign="top">-0.40</td><td align="center" valign="top">0.11</td><td align="center" valign="top">-3.569</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">0.67</td><td align="center" valign="top">0.53</td><td align="center" valign="top">0.83</td></tr><tr><td align="center" valign="top">Citrate</td><td align="center" valign="top">-0.45</td><td align="center" valign="top">0.11</td><td align="center" valign="top">-3.967</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">0.64</td><td align="center" valign="top">0.51</td><td align="center" valign="top">0.79</td></tr><tr><td align="center" valign="top">Phosphate</td><td align="center" valign="top">-0.05</td><td align="center" valign="top">0.14</td><td align="center" valign="top">-0.348</td><td align="center" valign="top">0.728</td><td align="center" valign="top">0.95</td><td align="center" valign="top">0.73</td><td align="center" valign="top">1.25</td></tr><tr><td align="center" valign="top">Calcium</td><td align="center" valign="top">0.95</td><td align="center" valign="top">0.15</td><td align="center" valign="top">6.219</td><td align="center" valign="top">&lt;0.001</td><td align="center" valign="top">2.59</td><td align="center" valign="top">1.93</td><td align="center" valign="top">3.53</td></tr><tr><td align="center" valign="top">Magnesium</td><td align="center" valign="top">-0.32</td><td align="center" valign="top">0.14</td><td align="center" valign="top">-2.227</td><td align="center" valign="top">0.026</td><td align="center" valign="top">0.73</td><td align="center" valign="top">0.55</td><td align="center" valign="top">0.96</td></tr><tr><td align="center" valign="top">Oxalate</td><td align="center" valign="top">-0.31</td><td align="center" valign="top">0.15</td><td align="center" valign="top">-2.097</td><td align="center" valign="top">0.036</td><td align="center" valign="top">0.73</td><td align="center" valign="top">0.54</td><td align="center" valign="top">0.97</td></tr></tbody></table></table-wrap></floats-group></article>